Contenido Relacionado

Contenido en el Idioma Español de University of Maryland Medical Center

Hepatitis A - Treatment

Nombres alternativos

Hepatitis viral; Hepatitis infecciosa

Tratamiento:

No existe ningún tratamiento específico para la hepatitis A, pero se recomienda el reposo cuando los síntomas son más intensos. Las personas con hepatitis aguda deben evitar el consumo de alcohol y cualquier sustancia que sea tóxica para el hígado, incluyendo el paracetamol (Tylenol).

Las comidas grasosas pueden causar vómito, debido a que las sustancias del hígado se necesitan para digerir las grasas, y lo mejor es evitarlas durante la fase aguda.

Pronóstico:

El virus no permanece en el cuerpo después de que la infección desaparece.

Más del 85% de las personas con hepatitis A se recuperan en un período de tres meses y casi todos los pacientes se recuperan dentro de un período de 6 meses.

Hay un bajo riesgo de muerte, generalmente entre los ancianos y personas con enfermedad hepática crónica.

Posibles complicaciones:

Generalmente no hay complicaciones. Uno de cada mil casos se convierte en hepatitis fulminante, que puede ser mortal.

Cuándo contactar a un profesional médico:

Solicite una cita con el médico si tiene síntomas de hepatitis.

El sistema digestivo

Mosca

Hepatitis A

Eritema multiforme, lesiones circulares en las manos

Órganos del sistema digestivo

Reviewed last on: 11/23/2010
David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and George F. Longstreth, MD, Department of Gastroenterology, Kaiser Permanente Medical Care Program, San Diego, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Referencias

Advisory Committee for Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Recommended immunization schedules for children, adolescents, and adults -- United States, 2010 (accessed November 9, 2010).

Advisory Committee for Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56:1080-1084.

Hoofnagle JH. Acute viral hepatitis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 151.

Sjogren MH, Cheatham JG. Hepatitis A. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 77.

Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med. 2007;357:1685-1694.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

Connect with UMMC

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538